Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT06608927 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06608927
- Sponsor
- Arcus Biosciences, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-13
- Primary completion
- 2030-11-30
- Enrollment
- 610
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.